At Valley Medical in Tempe, the Weekly Program is built to address each of those gaps directly.
Personalization. Your program starts with a medical intake evaluation a real conversation with a licensed provider about your health history, prior attempts, current medications, and specific goals. The plan you leave with is built for you. Not for a demographic. Not for whoever lost weight on the last trend.
Adjustment. Weekly check-ins mean your plan is never static for long. If something isn’t working the medication dose, the dietary approach, the pace of progress it gets adjusted. You don’t have to diagnose what changed or decide what to try next. Your provider does that with you, based on your actual data.
Clinical appetite support. When medically appropriate, our providers prescribe medications to help manage appetite. These are clinical decisions made by a licensed provider, not supplements selected off a shelf. For patients who qualify, compounded GLP-1 injections, either compounded semaglutide or compounded tirzepatide, may be incorporated as part of the supervised program.
Accountability. Weekly check-ins create a low-friction, consistent accountability structure. Patients who know they’re checking in next week make different daily decisions than those managing on their own. That’s a predictable human pattern, and building it into the program structure is part of what makes supervised care work where solo efforts have stalled.
Compounded semaglutide and tirzepatide are not FDA-approved finished drug products. They are not demonstrated to be bioequivalent to any branded medication and may differ in formulation, potency, or inactive ingredients. Both are always prescribed and monitored by a licensed provider as part of a supervised program.
